RHO FEDERAL SYSTEMS DIVISION INC

RHO FEDERAL SYSTEMS DIVISION INC specializes in end-to-end clinical research and data science support for federal health initiatives, with deep expertise in statistical coordination, clinical trial design, and safety assessment for complex biomedical studies. The contractor delivers integrated statistical and data coordinating center services, managing large-scale clinical trial networks, generating integrated safety summaries, and executing antigen-sparing and booster evaluation trials for vaccines and therapeutics. Their technical capabilities include clinical data management, adaptive trial methodology, regulatory-compliant reporting, and real-time analytics for public health emergencies, with a proven focus on influenza, anthrax countermeasures, and autoimmune disease research. The firm distinguishes itself through its precision in translating clinical outcomes into actionable regulatory science, supporting agencies with high-stakes, time-sensitive public health mandates. The contractor maintains a sustained relationship with the Department of Health and Human Services, consistently providing scientific and operational support for vaccine safety surveillance, clinical trial infrastructure, and biostatistical coordination across multiple programs. Their work for HHS centers on advancing clinical research standards and ensuring data integrity for federally funded biomedical studies. A single contract with the General Services Administration under the OASIS contract indicates capacity to deliver professional scientific services across multi-agency environments. The contractor’s primary focus is in NAICS 541715, encompassing physical, engineering, and life sciences R&D excluding nanotechnology and biotechnology—specifically applied to clinical research and statistical coordination. This positions them as a niche provider in regulatory science and clinical trial operations within the federal health research ecosystem. RHO FEDERAL SYSTEMS DIVISION INC is a small business entity headquartered in Durham, North Carolina, with no federal certifications on record. Their market presence is defined by deep technical engagement with HHS programs rather than broad diversification, reflecting a focused, mission-driven approach to federal health research support.